Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information on how we use and manage cookies please take a look at our privacy and cookie policies. Some parts of the site may not work properly if you choose not to accept cookies.

Home > SAS > IIA: Data and Analytics to Combat the Opioid Epidemic

IIA: Data and Analytics to Combat the Opioid Epidemic

White Paper Published By: SAS
Published:  Apr 04, 2018
Type:  White Paper
Length:  8 pages

Opioid use grabs headlines when important celebrities overdose. Prince is sadly the most recent. But the problem is persistent and pervasive. The marginally good news is that the number of opioid prescriptions written started to decline last year. Overdose deaths,
however, continued to rise. Also in the news have been lawsuits against pharmaceutical companies and distributors for helping to create the astounding oversupply of opioids, but the root causes go deeper.  Physicians and their patients, medical policy makers and licensing boards, pharma companies and pharmacies all have played roles. And all must work together to stem the opioid epidemic and achieve the fundamental objectives of reducing addiction and deaths.

Analytics should enable all of these players to be more forwardlooking and predictive, and to avoid unanticipated consequences of well-intentioned initiatives.

Tags :